Exolvo Biosciences, through collaboration with NLC and Verily, is advancing flexible capsule-sized oral drug delivery technology for large molecular structures, enhancing patient experience and healthcare delivery efficiency.
The need for Exolvo arises from the challenge of administering biologic drugs through painful injections, making treatments burdensome. The company's aim is to make treatments less invasive and more accessible for patients with chronic conditions.
#exolvo-biosciences #biologic-drug-delivery #innovative-technology #chronic-conditions #healthcare-efficiency
[
add
]
[
|
|
...
]